We are live on ! Find out more
SONN

Sonnet BioTherapeutics
SONN

Delisted

SONN was delisted on the 2nd of December, 2025.

Back to rankings

2 hedge funds and large institutions have $4.54M invested in Sonnet BioTherapeutics in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more capital invested

Capital invested by funds: $1.86M → $4.54M (+$2.68M)

Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$1.88M
2
EI
EAM Investors
California
+$1.88M

Top Sellers

Rank Fund Capital Flow
1
SWP
Stratos Wealth Partners
Ohio
-$34K
2
UBS Group
UBS Group
Switzerland
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
1
Bank of America
North Carolina
$996K +$1.88M +1 New
EI
2
EAM Investors
California
$981K +$1.88M +1 New
CCM
3
Coe Capital Management
Illinois
$717K – – –
Millennium Management
4
Millennium Management
New York
$498K – – –
TDC
5
Thompson Davis & Co
Virginia
$424K – – –
BIT
6
BlackRock Institutional Trust
California
$250K – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$205K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$113K – – –
CDH
9
Charles D. Hyman
$110K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$90K – – –
EVC
11
Eidelman Virant Capital
Missouri
$74K – – –
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$41K – – –
CL
13
CSS LLC
Illinois
$28K – – –
Walleye Trading
14
Walleye Trading
New York
$6K – – –
BIM
15
BlackRock Investment Management
Delaware
$5K – – –
Morgan Stanley
16
Morgan Stanley
New York
$3K – – –
SWP
17
Stratos Wealth Partners
Ohio
– -$34K – –
UBS Group
18
UBS Group
Switzerland
– -$6K – –

SONN Hedge Fund Activity: Q2 2015 in Review

2 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Sonnet BioTherapeutics (SONN) for Q2 2015, worth a combined $4.54M — up 144% from $1.86M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new SONN positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $1.88M. The largest seller was Stratos Wealth Partners, cutting an estimated $34K.

  • 2 institutional investors held Sonnet BioTherapeutics (SONN) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $4.54M of Sonnet BioTherapeutics stock for Q2 2015, up 144% quarter-over-quarter.
  • 2 funds opened new Sonnet BioTherapeutics positions in Q2 2015 and 0 closed out, a net change of +2 holders.
  • The largest Sonnet BioTherapeutics buyer in Q2 2015 was Bank of America, an estimated $1.88M added.
  • The largest Sonnet BioTherapeutics seller in Q2 2015 was Stratos Wealth Partners, an estimated $34K sold.

Based on aggregated 13F filings for Q2 2015.